Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting
Authors:
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 100 (2) , 146-152
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Serious Asthma Exacerbations in Asthmatics Treated With High-Dose FormoterolChest, 2003
- Safety of formoterol Turbuhaler® at cumulative dose of 90 µg in patients with acute bronchial obstructionEuropean Respiratory Journal, 2001
- Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trialThe Lancet, 2001
- Continuous Versus Intermittent Nebulization of Salbutamol in Acute Severe Asthma: A Randomized, Controlled TrialAnnals of Emergency Medicine, 2000
- Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: A controlled trialJournal of Allergy and Clinical Immunology, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study InvestigatorsThorax, 1997
- Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of actionEuropean Respiratory Journal, 1996
- Comparison of Addition of Salmeterol to Inhaled Steroids With Doubling of the Dose of Inhaled SteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994